AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 23rd Annual Needham Virtual Healthcare Conference.
AtriCure’s management is scheduled to participate in a fireside chat on Tuesday, April 9, 2024, at 1:30 p.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240326746925/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
[email protected]
Marissa Bych
Gilmartin Group
Investor Relations
[email protected]
Source: AtriCure, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
- XRP Price Prediction Turns Explosive at $1.48 While Pepeto Wallets Rush the Presale Before Listing
- Bitcoin Targets $77K After a Short Squeeze as XRP Jumps 20% and Apeing Enters the Best Upcoming Crypto Presale Race
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Needham & Company, Twitter, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share